These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34774042)

  • 1. Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis.
    Luo D; Luo Y; Zou Y; Xu Y; Fu B; Yang D; Yang J; Xu C; Ling S; Li S; Qi A
    Lipids Health Dis; 2021 Nov; 20(1):159. PubMed ID: 34774042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
    Echida Y; Ogawa T; Otsuka K; Ando Y; Nitta K
    Clin Exp Nephrol; 2012 Oct; 16(5):767-72. PubMed ID: 22374049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
    Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
    Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up.
    Harari G; Green MS; Magid A; Zelber-Sagi S
    Am J Cardiol; 2017 Apr; 119(8):1193-1198. PubMed ID: 28267961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.
    Wang G; Zhang Q; Zhao X; Dong H; Wu C; Wu F; Yu B; Lv J; Zhang S; Wu G; Wu S; Wang X; Wu Y; Zhong Y
    Lipids Health Dis; 2020 Sep; 19(1):204. PubMed ID: 32892746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.
    Chiang CK; Ho TI; Hsu SP; Peng YS; Pai MF; Yang SY; Hung KY; Tsai TJ
    Blood Purif; 2005; 23(2):134-40. PubMed ID: 15665509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients.
    Schreier L; González AI; Elbert A; Berg G; Wikinski R
    Metabolism; 2004 Aug; 53(8):1013-5. PubMed ID: 15281010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.
    van Deventer HE; Miller WG; Myers GL; Sakurabayashi I; Bachmann LM; Caudill SP; Dziekonski A; Edwards S; Kimberly MM; Korzun WJ; Leary ET; Nakajima K; Nakamura M; Shamburek RD; Vetrovec GW; Warnick GR; Remaley AT
    Clin Chem; 2011 Mar; 57(3):490-501. PubMed ID: 21228254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.